Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Chembio Diagnostics Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CEMI
Nasdaq
2835
http://chembio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Chembio Diagnostics Inc
French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M
- Feb 1st, 2023 4:01 pm
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
- Jan 31st, 2023 10:00 pm
Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System
- Nov 28th, 2022 1:00 pm
Chembio Diagnostics Reports Third Quarter 2022 Financial Results
- Nov 3rd, 2022 8:05 pm
Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022
- Oct 20th, 2022 8:05 pm
Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
- Sep 6th, 2022 12:00 pm
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
- Aug 26th, 2022 5:15 pm
Rapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It Off
- Aug 16th, 2022 3:50 pm
Chembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Development
- Aug 16th, 2022 12:00 pm
Chembio Diagnostics Reports Second Quarter 2022 Financial Results
- Aug 4th, 2022 8:05 pm
Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022
- Jul 21st, 2022 8:05 pm
Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel
- Jun 15th, 2022 12:00 pm
Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors
- May 24th, 2022 8:15 pm
Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility
- May 17th, 2022 12:00 pm
Chembio Diagnostics Reports First Quarter 2022 Financial Results
- May 5th, 2022 8:05 pm
Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022
- Apr 21st, 2022 8:05 pm
Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results
- Mar 3rd, 2022 9:05 pm
Chembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
- Feb 17th, 2022 9:05 pm
Scroll